Development of peptide inhibitors against dengue virus infection by in silico desigh and in vitro studies
Dengue virus (DENV) infection is a global major concern with over 50 million reported cases a year. Presently, there are neither any approved vaccines nor effective drugs that are available; therefore, the development of anti-DENV drug is urgently needed. Several clinical reports revealed a positive...
Saved in:
Main Author: | Aussara Panya |
---|---|
Other Authors: | Pa-thai Yenchitsomanus |
Language: | English |
Published: |
Mahidol University. Mahidol University Library and Knowledge Center
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/89738 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Language: | English |
Similar Items
-
Analysis of T cell responses in dengue virus infection
by: Wanwisa Dejnirattisai
Published: (2023) -
Antiviral activity of lanatoside C against dengue virus infection
by: Cheung, YY, et al.
Published: (2020) -
Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease
by: Schüller, A., et al.
Published: (2014) -
Targeting host factors to treat West Nile and dengue viral infections
by: Krishnan, M.N., et al.
Published: (2014) -
Effect of Thai medicinal plant extracts against dengue virus in vitro
by: N Klawikkan, et al.
Published: (2010)